The drug for the new coronavirus that Chugai applied for approval was approved by the Ministry of Health, Labor and Welfare on the night of the 19th.
It is called "antibody cocktail therapy" because it administers two drugs at the same time, and it is the first drug that can be used for mildly ill patients.
Approved are casirivimab and imdevimab, which Chugai applied for approval as a treatment for the new coronavirus at the end of last month.
By administering at the same time, we adopted a treatment method called "antibody cocktail therapy" in which two types of antibodies act to suppress the action of the virus, and in November last year we received permission for emergency use from the FDA = Food and Drug Administration in the United States. I am.
It was also used when former US President Trump was hospitalized before, and according to Chugai, clinical trials conducted overseas confirmed that it reduced the risk of hospitalization and death by about 70%.
On the 19th, the expert committee of the Ministry of Health, Labor and Welfare examined the approval or disapproval, and it was approved that it was approved as being recognized as effective and safe.
In response, the Ministry of Health, Labor and Welfare approved it as the fourth treatment after remdesivir, dexamethasone, and baricitinib on the night of the 19th.
It is targeted at mild to moderately ill patients and is the first treatment available to mildly ill patients.
From tomorrow to delivery to medical institutions Minister of Health, Labor and Welfare
Minister of Health, Labor and Welfare Tamura has revealed to reporters that Chugai has approved the drug for the new coronavirus, which has been submitted for approval, after discussions by an expert group of the Ministry of Health, Labor and Welfare.
After that, he explained that delivery to medical institutions will start on the 20th and will be administered to inpatients at risk of aggravation.
"It's a big step forward. We anticipate that vaccination will progress and the number of mildly ill patients will increase, so we hope to establish treatments for appropriate response." ..